172 related articles for article (PubMed ID: 36250723)
1.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
[TBL] [Abstract][Full Text] [Related]
3.
Wang Z; Yang Z; Shishido M; Daoudi K; Hidaka M; Tateno H; Futai E; Ogawa T
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928400
[TBL] [Abstract][Full Text] [Related]
4. Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA.
Cobre AF; Maia Neto M; de Melo EB; Fachi MM; Ferreira LM; Tonin FS; Pontarolo R
J Biomol Struct Dyn; 2024 Jul; 42(11):5881-5894. PubMed ID: 37394802
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection.
Tai LT; Yeh CY; Chang YJ; Liu JF; Hsu KC; Cheng JC; Lu CH
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892294
[TBL] [Abstract][Full Text] [Related]
6. Structural, dynamic behaviour, in-vitro and computational investigations of Schiff's bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein.
Ullah S; Ullah A; Waqas M; Halim SA; Pasha AR; Shafiq Z; Mali SN; Jawarkar RD; Khan A; Khalid A; Abdalla AN; Kashtoh H; Al-Harrasi A
Sci Rep; 2024 Jun; 14(1):12588. PubMed ID: 38822113
[TBL] [Abstract][Full Text] [Related]
7. Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study.
Aatif M; Muteeb G; Alsultan A; Alshoaibi A; Khelif BY
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922914
[TBL] [Abstract][Full Text] [Related]
8. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
[TBL] [Abstract][Full Text] [Related]
9. Computational analysis of affinity dynamics between the variants of SARS-CoV-2 spike protein (RBD) and human ACE-2 receptor.
Sultana N; Nagesha SN; Reddy CNL; Ramesh BN; Shyamalamma S; Shashidhara KS; Satish KM; Pradeep C; Vidyadhar GD
Virol J; 2024 Apr; 21(1):88. PubMed ID: 38641844
[TBL] [Abstract][Full Text] [Related]
10. Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.
Nangarlia A; Hassen FF; Canziani G; Bandi P; Talukder C; Zhang F; Krauth D; Gary EN; Weiner DB; Bieniasz P; Navas-Martin S; O'Keefe BR; Ang CG; Chaiken I
Biochemistry; 2023 Jul; 62(14):2115-2127. PubMed ID: 37341186
[TBL] [Abstract][Full Text] [Related]
11. Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study.
Morgon NH; Grandini GS; Yoguim MI; Porto CM; Santana LC; Biswas S; de Souza AR
J Mol Model; 2021 Jul; 27(8):222. PubMed ID: 34236527
[TBL] [Abstract][Full Text] [Related]
12. Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2.
Salih AEM; Thissera B; Yaseen M; Hassane ASI; El-Seedi HR; Sayed AM; Rateb ME
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436245
[TBL] [Abstract][Full Text] [Related]
13. The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2.
Otazu K; Olivos-Ramirez GE; Fernández-Silva PD; Vilca-Quispe J; Vega-Chozo K; Jimenez-Avalos GM; Chenet-Zuta ME; Sosa-Amay FE; Cárdenas Cárdenas RG; Ropón-Palacios G; Dattani N; Camps I
J Mol Model; 2024 Jun; 30(7):217. PubMed ID: 38888748
[TBL] [Abstract][Full Text] [Related]
14. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
Muñoz-Basagoiti J; Monteiro FLL; Krumpe LRH; Armario-Najera V; Shenoy SR; Perez-Zsolt D; Westgarth HJ; Villorbina G; Bomfim LM; Raïch-Regué D; Nogueras L; Henrich CJ; Gallemí M; Moreira FRR; Torres P; Wilson J; D'arc M; Marfil S; Herlinger AL; Pradenas E; Higa LM; Portero-Otin M; Trinité B; Twyman RM; Capell T; Tanuri A; Blanco J; Izquierdo-Useros N; Rech EL; Christou P; O'Keefe BR
Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2214561120. PubMed ID: 36853940
[TBL] [Abstract][Full Text] [Related]
15. [Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion].
Yang C; Cheng C; Wang J; Chen K; Zhan J; Pan X; Xu X; Xu W; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):475-482. PubMed ID: 33963705
[TBL] [Abstract][Full Text] [Related]
16. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
17. Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations.
Jani V; Koulgi S; Uppuladinne MVN; Thrigulla SR; Gundeti M; Prasad GP; Kumar S; Narayanam S; Sonavane U; Joshi R
Curr Res Struct Biol; 2024; 7():100151. PubMed ID: 38881558
[TBL] [Abstract][Full Text] [Related]
18. Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A.
Klevanski M; Kim H; Heilemann M; Kuner T; Bartenschlager R
Antiviral Res; 2024 May; 225():105856. PubMed ID: 38447646
[TBL] [Abstract][Full Text] [Related]
19. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
Freidel MR; Vakhariya PA; Sardarni SK; Armen RS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675980
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo validation of the antiviral effect of hCypA against SARS-CoV-2 via binding to the RBD of spike protein.
Shin WR; Kim DY; Kim SY; Ahn G; Park DY; Min J; Ahn JY; Kim YH
Mol Ther; 2024 Jun; 32(6):1805-1816. PubMed ID: 38532628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
